PLSE Latest Press Releases

-- November 6, 2026 --

Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting Business Wire 7:00 AM

-- November 5, 2026 --

Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results Business Wire 4:05 PM

-- October 29, 2026 --

Pulse Biosciences to Present at Stifel 2026 Healthcare Conference Business Wire 1:05 PM

-- October 22, 2026 --

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026 Business Wire 4:05 PM

-- October 14, 2026 --

Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center Business Wire 7:00 AM

-- October 9, 2026 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- October 8, 2026 --

Pulse Biosciences' nPulse Technology to be Featured at the 21st Annual International VT Symposium 2026 Business Wire 7:00 AM

-- October 7, 2026 --

Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation Treatment Business Wire 7:00 AM

-- September 15, 2026 --

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse Vybrance Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules Business Wire 7:00 AM

-- September 4, 2026 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

-- August 18, 2026 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

-- August 6, 2026 --

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results Business Wire 4:05 PM

-- July 30, 2026 --

Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference Business Wire 4:05 PM

-- July 29, 2026 --

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study Business Wire 7:00 AM

-- July 21, 2026 --

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 Business Wire 4:05 PM

-- July 15, 2026 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

Market Data Delayed 15 Minutes